While on Wall Street, young innovative companies flock to the gate to go public, only one Swiss company had taken this step this year: ADC Therapeutics. HeiQ followed suit on Monday. Last June, the Vaud company opted for the Nasdaq, the Zurich start-up has favored the London Stock Exchange to attract investors.
Carried by the pandemic
Active in innovative textiles, this spin-off of the Swiss Federal Institute of Technology in Zurich is one of the winners of the coronavirus crisis. Its leaders have used their know-how to develop a new antiviral product that blocks the passage of SARS-Cov-2.
–
–
:quality(85)//cloudfront-us-east-1.images.arcpublishing.com/infobae/F7J4PNQFG5FB5GCCL5VL74C3NI.jpg?resize=150%2C150&ssl=1)
